Biomea Fusion Statistics
NASDAQ: BMEAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.37+0.05 (+3.79%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 1.37 0.00%
Biomea Fusion by the numbers
Biomea Fusion has a market capitalization of $99.1 million based on 72.30M shares outstanding. With trailing EPS of $-0.29, Biomea Fusion is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.7% below its 50-day average and 3.1% below its 200-day average.
Average daily trading volume is 1.47M shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BMEA valuation vs. peer median
| Metric | BMEA | Peer median | Difference |
|---|---|---|---|
| Market cap | $99.05M | $102.46M | -3% |
| Avg. volume | 1.47M | 269.77K | +446% |
Peer median across 8 companies: PLYX, KZIA, ANIX, CRBP, SDEV, AARD, IMUX, CPIX.
Valuation
- Market cap
- $99.05M
- EPS (TTM)
- $-0.29
- Shares outstanding
- 72.30M
Price and trading
- Previous close
- 1.32
- Open
- 1.32
- Day range
- 1.30 – 1.38
- 52-week range
- 0.872 – 2.24
- 52-week change
- -18.45%
- Beta
- —
- Volume
- 1.69M
- Average volume
- 1.47M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 99.05M
- Forward Pe
- -1.46
- Eps
- -0.29
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.24
- Week52 Low
- 0.87
- Avg Volume
- 1.47M
- Shares Outstanding
- 72.30M
- Ma50
- 1.50
- Ma200
- 1.41
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -38.76%
- Pct From52w Low
- 57.11%